Cellebrite DI Ltd. CLBT
11.62 USD +0.09 (+0.74%)
As ofNov 16, 2026, 10:25 AM EST
11.32 Day range 11.87
9.58 52-week range 19.39
- YTD
- -35.58%
- 1 year
- -37.05%
News
seekingalpha.com Cellebrite DI: Continuous Innovation Including AI Can Drive Growth Cellebrite DI combines double-digit growth and an attractive valuation, positioning the stock for a potential reversal of its multiyear downtrend. Q3 revenue rose 18% to $149 million and ARR…
prnewswire.com Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT) Cellebrite DI reported third-quarter results above key estimates on November 12, 2026, yet its shares traded down about 14% after the same report trimmed full-year revenue guidance again. Investors…benzinga.com JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $15 JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and lowers the price target from $16 to $15.
seekingalpha.com Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call Transcript Cellebrite DI Ltd. ( CLBT ) Q3 2026 Earnings Call November 12, 2026 8:30 AM EST Company Participants Andrew Kramer - VP of Investor Relations & Treasury Shiven Ramji - CEO & Director David Barter -…
marketbeat.com Cellebrite DI Q3 Earnings Call Highlights Cellebrite DI NASDAQ: CLBT reported third-quarter revenue and annual recurring revenue growth of 18% and 20%, respectively, as international sales and improving U.S. federal demand helped the digital…
zacks.com Cellebrite DI Ltd. (CLBT) Q3 Earnings Meet Estimates Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate.benzinga.com Cellebrite DI Lowers FY2026 Sales Guidance from $555.000M-$561.000M to $553.000M-$558.000M vs $556.733M Est Cellebrite DI (NASDAQ:CLBT) lowers FY2026 sales outlook from $555.000 million-$561.000 million to $553.000 million-$558.000 million vs $556.733 million estimate.
benzinga.com Cellebrite DI Q3 Adj. EPS $0.17 Beats $0.16 Estimate, Sales $149.022M Beat $145.923M Estimate Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.16 by 6.25 percent. This is a 21.43 percent increase over earnings of $0.14…
benzinga.com Cellebrite DI Sees Q4 Sales $145.000M-$150.000M vs $151.451M Est Cellebrite DI (NASDAQ:CLBT) sees Q4 sales of $145.000 million-$150.000 million vs $151.451 million analyst estimate.
prnewswire.com Cellebrite Reports Third-Quarter 2026 Results Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin…
prnewswire.com Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026 TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 9, 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the…
